The global chronic hepatitis B treatment market is undergoing significant growth. This trend can be attributed to a number of factors, including an elevating population, improved diagnostic capabilities, and growing awareness about the disease. The market is further driven by developments in treatment approaches, such as antiviral therapies. A key